Anders Waage

10PUBLICATIONS
103CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Predictive and prognostic markersMicrobial geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 02, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myeloma.

Karolos Douvlataniotis, Aleksei Titov, Julia Zeun

|Jan 27, 2025
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone.

Tobias S Slørdahl, Frida Bugge Askeland, Margrete Sofie Sætre Hanssen

|Aug 05, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myeloma.

Molly Went, Laura Duran-Lozano, Gisli H Halldorsson

|Apr 15, 2024
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

Thomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted

|Jul 07, 2023
Potential value of pre-planned imaging of bone disease in multiple myeloma.

Michael T Gundesen, Jon Thor Asmussen, Fredrik Schjesvold

|Nov 29, 2022
Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival.

Kristin Roseth Aass, Tonje Marie Vikene Nedal, Siri Anshushaug Bouma

Pageof 2

Frequent Collaborators

4 joint publications

Fredrik Schjesvold

4 joint publications

Tobias Schmidt Slørdahl

3 joint publications

Annette Juul-Vangsted

2 joint publications

Mario Boccadoro